Appoints Dr. Scott Lyon as Director of Business Development located on West Coast, USA Moves to larger Headquarters in Cambridge, UK CAMBRIDGE, UK – Optibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge […]

CDD Expansion News CDD’s primary mission has always included the promotion and empowerment of collaborations for our customers. Sometimes, these customer collaborations are isolated within groups located across the hall from one another, and other times they involve truly global partnerships. What you may not realize is that CDD also encourages and adopts this collaborative […]

Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]

Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY - Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]

New York, NY - Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has received a payment from Sanofi for reaching a major milestone in its multi-year, multi-target drug discovery collaboration. The project in which the milestone was achieved is one of several programs that Schrödinger is […]

BUDAPEST, Hungary and TOULOUSE, France and BOSTON — ChemAxon, a leading provider of cheminformatics software for life sciences announces a strategic partnership with DEXSTR, an innovative provider of Scientific Knowledge Management solutions. Organizations have an unprecedented quantity of continuously generated unstructured data. Inquiro, DEXSTR’s Scientific Knowledge Management System significantly enhances the R&D digitalization process, turning unstructured data into actionable insight. […]

Collaboration to Focus on Computational Chemistry and Molecular Recognition in the Human Body NEW YORK, NY and SHANGHAI, CHINA (November 7, 2017) – Schrödinger, Inc., a world-leading provider of advanced molecular simulations and drug discovery software solutions, and ShanghaiTech University in China have reached an agreement to develop a strategic partnership and establish the Shanghai […]

New Informatics Solution for Biologics Discovery Helps Multidisciplinary and Multi-Organizational Teams Capture and Track Projects   Bishop’s Stortford, England – Dotmatics, a leading provider of scientific informatics solutions and services, today announced major global biologics capabilities and the addition of key personnel and workflows that allow discovery teams to capture experiments, processes, and improve decision-support based on […]

NEW YORK, NY– Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced the appointment of Dov Goldstein, M.D., as Chief Financial Officer. Dr. Goldstein brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a […]